American journal of surgery · 2025
Investigating racial/ethnic disparities in opioid use among patients undergoing gastrointestinal cancer surgery.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zindani Shahzaib, Rashid Zayed, Woldesenbet Selamawit, Khalil Mujtaba, Pawlik Timothy M
Аннотация
INTRODUCTION: We sought to investigate racial/ethnic disparities in opioid prescribing patterns among patients undergoing gastrointestinal (GI) cancer surgery.
METHODS: Patients who underwent surgery for GI cancer (2016-2023) were identified using the EPIC Cosmos database. Multivariate analyses were conducted to assess differences in opioid prescription patterns postoperatively.
RESULTS: 168,220 individuals underwent GI cancer surgery (esophagus: 2.5 %; stomach: 4.1 %, pancreas: 9.7 %; hepatobiliary: 6.4 %; colorectal: 77.3 %); 52.9 % were male, 86.0 % were White with median age of 72 years (IQR: 62-80). Black patients were younger (68 years [IQR: 60-76] vs. 72 years [IQR: 63-81]) and had a lower Charlson Comorbidity Index score (>2) (66.2 % vs. 68.5 %) compared with White patients (both p < 0.001). On multivariable analysis, Black patients had similar odds of receiving opioids as White patients (OR: 1.01, 95 % CI: 0.95-1.08).
CONCLUSION: No race-based differences were noted in the use of opioid prescriptions, duration of prescriptions, or mode of opioid administration following GI surgery.
METHODS: Patients who underwent surgery for GI cancer (2016-2023) were identified using the EPIC Cosmos database. Multivariate analyses were conducted to assess differences in opioid prescription patterns postoperatively.
RESULTS: 168,220 individuals underwent GI cancer surgery (esophagus: 2.5 %; stomach: 4.1 %, pancreas: 9.7 %; hepatobiliary: 6.4 %; colorectal: 77.3 %); 52.9 % were male, 86.0 % were White with median age of 72 years (IQR: 62-80). Black patients were younger (68 years [IQR: 60-76] vs. 72 years [IQR: 63-81]) and had a lower Charlson Comorbidity Index score (>2) (66.2 % vs. 68.5 %) compared with White patients (both p < 0.001). On multivariable analysis, Black patients had similar odds of receiving opioids as White patients (OR: 1.01, 95 % CI: 0.95-1.08).
CONCLUSION: No race-based differences were noted in the use of opioid prescriptions, duration of prescriptions, or mode of opioid administration following GI surgery.